{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T04:55:16Z","timestamp":1769921716178,"version":"3.49.0"},"reference-count":77,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,26]],"date-time":"2023-01-26T00:00:00Z","timestamp":1674691200000},"content-version":"vor","delay-in-days":25,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Open Respiratory Archives"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.opresp.2023.100234","type":"journal-article","created":{"date-parts":[[2023,2,3]],"date-time":"2023-02-03T03:16:30Z","timestamp":1675394190000},"page":"100234","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Infecci\u00f3n bronquial cr\u00f3nica en EPOC estable"],"prefix":"10.1016","volume":"5","author":[{"given":"Juan Jos\u00e9","family":"Soler-Catalu\u00f1a","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel Angel","family":"Martinez-Garcia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.opresp.2023.100234_bib0390","doi-asserted-by":"crossref","first-page":"020415","DOI":"10.7189\/jogh.05.020415","article-title":"Global and regional estimates of COPD prevalence: Sytematic review and meta-analysis","volume":"5","author":"Adeloye","year":"2015","journal-title":"J Glob Health."},{"key":"10.1016\/j.opresp.2023.100234_bib0395","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/S2213-2600(21)00555-5","article-title":"Pathogenesis of COPD: understanding the contributions of gene-environment interactions acreoss the lifespan","volume":"10","author":"Agusti","year":"2022","journal-title":"Lancet Respir med."},{"key":"10.1016\/j.opresp.2023.100234_bib0400","unstructured":"Global initiative for chronic obstructive lung disease (2023 report). [consultado 12 Dic 2022]. Disponible en: www.goldcopd.org."},{"key":"10.1016\/j.opresp.2023.100234_bib0405","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1136\/thx.2005.040527","article-title":"Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease","volume":"60","author":"Soler-Catalu\u00f1a","year":"2005","journal-title":"Thorax."},{"key":"10.1016\/j.opresp.2023.100234_bib0410","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.arbres.2021.03.005","article-title":"Actualizaci\u00f3n 2021 de la Gu\u00eda Espa\u00f1ola de la EPOC (GesEPOC) Tratamiento farmacol\u00f3gico de la EPOC estable","volume":"58","author":"Miratvilles","year":"2022","journal-title":"Arch Bronconeumol."},{"key":"10.1016\/j.opresp.2023.100234_bib0415","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.arbres.2020.04.023","article-title":"Consensus document on the diagnosis and treatment of chronic bronchial infection in chronic obstructive pulmonary disease","volume":"56","author":"De la Rosa Carrillo","year":"2020","journal-title":"Arch Bronconeumol."},{"key":"10.1016\/j.opresp.2023.100234_bib0420","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.arbres.2017.07.016","article-title":"Spanish guidelines on treatment of bronchiectasis in adults","volume":"54","author":"Mart\u00ednez-Garc\u00eda","year":"2018","journal-title":"Arch Bronconeumol."},{"key":"10.1016\/j.opresp.2023.100234_bib0425","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.arbr.2014.09.018","article-title":"Spanish Consensus on the Prevention and Treatment of Pseudomonas aeruginosa Bronchial Infections in Cystic Fibrosis Patients","volume":"51","author":"Canton","year":"2015","journal-title":"Arch Bronconeumol."},{"key":"10.1016\/j.opresp.2023.100234_bib0430","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.3390\/biomedicines10061337","article-title":"Impact of lung microbiota on COPD","volume":"10","author":"Russo","year":"2022","journal-title":"Biomedicines."},{"key":"10.1016\/j.opresp.2023.100234_bib0435","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.3390\/jcm9061639","article-title":"Current challenges in chronic bronchial infection in patients with chronic obstructive pulmonary disease","volume":"9","author":"Lopez-Campos","year":"2020","journal-title":"J Clin Med."},{"key":"10.1016\/j.opresp.2023.100234_bib0440","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1164\/rccm.200210-1179OC","article-title":"Airway bacterial load and FEV1 decline in patients with chronic obstructive pulmonary disease","volume":"167","author":"Wilkinson","year":"2003","journal-title":"Am J Respir Crit Care Med."},{"key":"10.1016\/j.opresp.2023.100234_bib0445","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1513\/AnnalsATS.202108-974OC","article-title":"Chronic bronchial infection is associated with more rapid lung decline in COPD","volume":"19","author":"Mart\u00ednez-Garc\u00eda","year":"2022","journal-title":"Ann Am Thorac Soc."},{"key":"10.1016\/j.opresp.2023.100234_bib0450","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.rmed.2012.10.024","article-title":"Chronic bronchial infection in COPD Is there an infective phenotype?","volume":"107","author":"Matkovic","year":"2013","journal-title":"Respir Med."},{"issue":"3","key":"10.1016\/j.opresp.2023.100234_bib0455","doi-asserted-by":"crossref","first-page":"1700629","DOI":"10.1183\/13993003.00629-2017","article-title":"European Respiratory Society guidelines for the management of adult bronchiectasis","volume":"50","author":"Polverino","year":"2017","journal-title":"Eur Respir J."},{"key":"10.1016\/j.opresp.2023.100234_bib0460","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.arbres.2017.07.015","article-title":"Spanish guidelines on the evaluation and diagnosis of bronchiectasis in adults","volume":"54","author":"Mart\u00ednez-Garc\u00eda","year":"2018","journal-title":"Arch Bronconeumol."},{"key":"10.1016\/j.opresp.2023.100234_bib0465","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1164\/rccm.201908-1550OC","article-title":"Inhaled steroids, circulating eosinophils, chronic airway infection and pneumonia risk in chronic obstructive pulmonary disease: a network analysis","volume":"201","author":"Mart\u00ednez-Garc\u00eda","year":"2020","journal-title":"Am J Respir Crit Care Med."},{"key":"10.1016\/j.opresp.2023.100234_bib0470","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1111\/resp.14086","article-title":"Chronic bronchial infection and incident cardiovascular events in chronic obstructive pulmonary disease patients: a long-term observational study","volume":"26","author":"Mart\u00ednez-Garc\u00eda","year":"2021","journal-title":"Respirology."},{"key":"10.1016\/j.opresp.2023.100234_bib0475","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1001\/archinte.165.8.891","article-title":"Microbiologic determinants of exacerbation in chronic obstructive pulmonary disease","volume":"165","author":"Rosell","year":"2005","journal-title":"Arch Intern Med."},{"key":"10.1016\/j.opresp.2023.100234_bib0480","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/resp.13032","article-title":"The role of acute and chronic respiratory colonization and infections in the pathogenesis of COPD","volume":"22","author":"Leung","year":"2017","journal-title":"Respirology."},{"key":"10.1016\/j.opresp.2023.100234_bib0485","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/1465-9921-11-58","article-title":"Colour of sputum is a marker for bacterial colonisation in chronic obstructive pulmonary disease","volume":"11","author":"Miravitlles","year":"2010","journal-title":"Respir Res."},{"key":"10.1016\/j.opresp.2023.100234_bib0490","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1034\/j.1399-3003.1999.13b20.x","article-title":"Risk factors for lower airway bacterial colonization in chronic obstructive pulmonary disease","volume":"13","author":"Monso","year":"1999","journal-title":"Eur Respir J."},{"key":"10.1016\/j.opresp.2023.100234_bib0495","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1034\/j.1399-3003.1999.13b21.x","article-title":"Predisposing factros to bacterial colonization in chronic obstructive pulmonary disease","volume":"13","author":"Zalacain","year":"1999","journal-title":"Eur Respir J."},{"key":"10.1016\/j.opresp.2023.100234_bib0500","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1136\/thorax.57.9.759","article-title":"Relationship between bacterial colonization and the frequency, character, and severity of COPD exacerbations","volume":"57","author":"Patel","year":"2002","journal-title":"Thorax."},{"key":"10.1016\/j.opresp.2023.100234_bib0505","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1378\/chest.10-1758","article-title":"Factors associated with bronchiectasis in chronic obstructive pulmonary disease","volume":"140","author":"Mart\u00ednez-Garc\u00eda","year":"2011","journal-title":"Chest."},{"key":"10.1016\/j.opresp.2023.100234_bib0510","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1097\/MCP.0b013e328321861a","article-title":"Pseudomonas aeruginosa in adults with chronic obstructive pulmonary disease","volume":"15","author":"Murphy","year":"2009","journal-title":"Curr Opin Pulm Med."},{"key":"10.1016\/j.opresp.2023.100234_bib0515","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/1471-2466-14-103","article-title":"Pseudomonas aeruginosa isolates in severe chronic obstructive pulmonary disease: Characterization and risk factors","volume":"14","author":"Gallego","year":"2014","journal-title":"BMC Pulm Med."},{"key":"10.1016\/j.opresp.2023.100234_bib0520","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1164\/rccm.200311-1521OC","article-title":"Impact of cigarette smoke on clearance and inflammation after pseudomonas aeruginosa infection","volume":"170","author":"Drannik","year":"2004","journal-title":"Am J Respir Crit Care Med."},{"key":"10.1016\/j.opresp.2023.100234_bib0525","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1080\/15412555.2021.1884214","article-title":"Risk factors and relation with mortality of a new acquisition and persistence of Pseudomonas aeruginosa in COPD patients","volume":"18","author":"Martinez-Garcia","year":"2021","journal-title":"COPD."},{"key":"10.1016\/j.opresp.2023.100234_bib0530","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1164\/rccm.200509-1525OC","article-title":"Airway inflammation and bronchial bacterial colonization in chronic obstructive pulmonary disease","volume":"173","author":"Sethi","year":"2006","journal-title":"Am J Respir Crit Care Med."},{"key":"10.1016\/j.opresp.2023.100234_bib0535","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1513\/AnnalsATS.201310-350OC","article-title":"Bacterial colonization increases daily symptoms in patients with chronic obstructive pulmonary disease","volume":"11","author":"Desai","year":"2014","journal-title":"Ann Am Thorac Soc."},{"key":"10.1016\/j.opresp.2023.100234_bib0540","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.2147\/COPD.S117079","article-title":"Sputum microbiology predicts health status in COPD","volume":"11","author":"Braeken","year":"2016","journal-title":"Int J Chron Obstruct Pulmon Dis."},{"issue":"12","key":"10.1016\/j.opresp.2023.100234_bib0545","doi-asserted-by":"crossref","first-page":"3800","DOI":"10.3390\/jcm9123800","article-title":"Impact of Pseudomonas aeruginosa infection on patients with chronic inflammatory airway diseases","volume":"9","author":"Garcia-Clemente","year":"2020","journal-title":"J Clin Med."},{"key":"10.1016\/j.opresp.2023.100234_bib0550","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.cmi.2019.06.011","article-title":"Pseudomonas aeruginosa and risk of death and exacerbations in patients with chronic obstructive pulmonary disease: an observational cohort study of 22 053 patients","volume":"26","author":"Ekl\u00f6f","year":"2020","journal-title":"Clin Microbiol Infect."},{"issue":"1","key":"10.1016\/j.opresp.2023.100234_bib0555","doi-asserted-by":"crossref","first-page":"ofz546","DOI":"10.1093\/ofid\/ofz546","article-title":"Impact of Pseudomonas aeruginosa Isolation on Mortality and Outcomes in an Outpatient Chronic Obstructive Pulmonary Disease Cohort","volume":"7","author":"Jacobs","year":"2020","journal-title":"Open Forum Infect Dis."},{"issue":"3","key":"10.1016\/j.opresp.2023.100234_bib0560","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1183\/09031936.00023414","article-title":"Does a single Pseudomonas aeruginosa isolation predict COPD mortality?","volume":"44","author":"Boutou","year":"2014","journal-title":"Eur Respir J."},{"key":"10.1016\/j.opresp.2023.100234_bib0565","doi-asserted-by":"crossref","first-page":"371","DOI":"10.2147\/COPD.S346294","article-title":"Long-Term Risk of Mortality Associated with Isolation of Pseudomonas aeruginosa in COPD: A Systematic Review and Meta-Analysis","volume":"17","author":"Martinez-Garcia","year":"2022","journal-title":"Int J Chron Obstruct Pulmon Dis."},{"issue":"12","key":"10.1016\/j.opresp.2023.100234_bib0570","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1086\/593186","article-title":"Chronic Pseudomonas aeruginosa infection in chronic obstructive pulmonary disease","volume":"47","author":"Mart\u00ednez-Solano","year":"2008","journal-title":"Clin Infect Dis."},{"issue":"12","key":"10.1016\/j.opresp.2023.100234_bib0575","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1086\/648404","article-title":"Pseudomonas aeruginosa population biology in chronic obstructive pulmonary disease","volume":"200","author":"Rakhimova","year":"2009","journal-title":"J Infect Dis."},{"key":"10.1016\/j.opresp.2023.100234_bib0580","doi-asserted-by":"crossref","first-page":"10872","DOI":"10.3390\/ijms221910872","article-title":"The lung microbiome during health and disease","volume":"22","author":"Yagi","year":"2021","journal-title":"Int J Mol Sci."},{"key":"10.1016\/j.opresp.2023.100234_bib0585","doi-asserted-by":"crossref","first-page":"7828","DOI":"10.1038\/ncomms8828","article-title":"A biphasic epigenetic switch controls immunoevasion, virulence and niche adaptation in non-typeable Haemophilus influenzae","volume":"6","author":"Atack","year":"2015","journal-title":"Nat Commun."},{"key":"10.1016\/j.opresp.2023.100234_bib0590","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1378\/chest.116.1.40","article-title":"Relationship between bacterial flora in sputum and functional impairment in patients with acute exacerbations of COPD","volume":"116","author":"Miravitlles","year":"1999","journal-title":"Chest."},{"key":"10.1016\/j.opresp.2023.100234_bib0595","doi-asserted-by":"crossref","first-page":"881","DOI":"10.2147\/COPD.S78748","article-title":"Patients with chronic obstructive pulmonary disease and chronically colonized with Haemophilu influenzae during stable disease phase have increased airway inflammation","volume":"10","author":"Tufvesson","year":"2015","journal-title":"Int J Chron Obstruct Pulmon Dis."},{"issue":"12","key":"10.1016\/j.opresp.2023.100234_bib0600","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1164\/rccm.201806-1095OC","article-title":"Human Rhinovirus Impairs the Innate Immune Response to Bacteria in Alveolar Macrophages in Chronic Obstructive Pulmonary Disease","volume":"199","author":"Finney","year":"2019","journal-title":"Am J Respir Crit Care Med."},{"key":"10.1016\/j.opresp.2023.100234_bib0605","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1164\/rccm.200912-1843CC","article-title":"Chronic obstructive pulmonary disease phenotypes. The future of COPD","volume":"182","author":"Han","year":"2010","journal-title":"Am J Respir Crit Care Med."},{"key":"10.1016\/j.opresp.2023.100234_bib0610","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S2213-2600(15)00106-X","article-title":"Blood eosinophils counts, exacerbations, and responsse to the addition of inhaled fluticasone furoate to vilanterol in patients with chronic obstructive pulmonary disease\u00a0: a secondary analysis of data from two parallel randomised controlled trials","volume":"3","author":"Pascoe","year":"2015","journal-title":"Lancet Respir Med."},{"issue":"18","key":"10.1016\/j.opresp.2023.100234_bib0615","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1056\/NEJMoa1713901","article-title":"Once-Daily Single-Inhaler Triple versus Dual Therapy in Patients with COPD","volume":"378","author":"Lipson","year":"2018","journal-title":"N Engl J Med."},{"key":"10.1016\/j.opresp.2023.100234_bib0620","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1164\/rccm.202006-2618OC","article-title":"Reduced all-cause mortality in the ETHOS trial of budesonide\/glycopyrrolate \/formoterol for chronic obstructive pulmonary disease. A randomized, double-blind, multicenter, parallel-group study","volume":"203","author":"Martinez","year":"2021","journal-title":"Am J Respir Crit Care Med."},{"key":"10.1016\/j.opresp.2023.100234_bib0625","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.arbres.2021.03.005","article-title":"Spanish COPD guidelines (GesEPOC): Updated pharmacological treatment of stable COPD","volume":"58","author":"Miravitlles","year":"2022","journal-title":"Arch Bronconeumol."},{"key":"10.1016\/j.opresp.2023.100234_bib0630","unstructured":"Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease 2023. [consultado 01 Dic 2022]. Disponible en: www.goldcopd.org."},{"key":"10.1016\/j.opresp.2023.100234_bib0635","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1164\/rccm.202201-0209PP","article-title":"Blood eosinophils and chronic obstructive pulmonary disease: a global initiative for chronic obstructive lung disease committee 2022 Review","volume":"206","author":"Singh","year":"2022","journal-title":"Am J Respir Crit Care Med."},{"key":"10.1016\/j.opresp.2023.100234_bib0640","first-page":"CD010115","article-title":"Inhaled steroids and risk of pneumonia for chronic obstructive pulmonary disease","author":"Kew","year":"2014","journal-title":"Cochrane Database Syst Rev."},{"key":"10.1016\/j.opresp.2023.100234_bib0645","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1136\/thoraxjnl-2012-202872","article-title":"Inhaled corticosteroids in COPD and the risk of serious pneumonia","volume":"68","author":"Suissa","year":"2013","journal-title":"Thorax."},{"key":"10.1016\/j.opresp.2023.100234_bib0650","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.2147\/COPD.S209273","article-title":"Inhaled Corticosteroids and Risk of Tuberculosis in Patients with Obstructive Lung Diseases: A Systematic Review and Meta-Analysis of Non-randomized Studies","volume":"14","author":"Castellana","year":"2019","journal-title":"Int J Chron Obstruct Pulmon Dis."},{"key":"10.1016\/j.opresp.2023.100234_bib0655","doi-asserted-by":"crossref","first-page":"1700037","DOI":"10.1183\/13993003.00037-2017","article-title":"The risk of mycobacterial infections associated with inhaled corticosteroid use","volume":"50","author":"Brode","year":"2017","journal-title":"Eur Respir J."},{"key":"10.1016\/j.opresp.2023.100234_bib0660","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.arbres.2021.05.011","article-title":"Spanish COPD guidelines (GesEPOC) 2021 Updated diagnosis and treatment of COPD exacerbation syndrome","volume":"58","author":"Soler-Catalu\u00f1a","year":"2022","journal-title":"Arch Bronconeumol."},{"key":"10.1016\/j.opresp.2023.100234_bib0665","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.arbres.2020.07.008","article-title":"Exacerbation syndrome in COPD: A paradigm shift","volume":"57","author":"Soler-Catalu\u00f1a","year":"2021","journal-title":"Arch Bronconeumol."},{"key":"10.1016\/j.opresp.2023.100234_bib0670","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1164\/rccm.201104-0597OC","article-title":"Acute Exacerbations of COPD: Identification of Biological Clusters and Their Biomarkers","volume":"184","author":"Bafadhel","year":"2011","journal-title":"Am J Respir Crit Care Med."},{"key":"10.1016\/j.opresp.2023.100234_bib0675","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1183\/13993003.01406-2015","article-title":"Lung microbiome dynamics in COPD exacerbations","volume":"47","author":"Wang","year":"2016","journal-title":"Eur Respir J."},{"key":"10.1016\/j.opresp.2023.100234_bib0680","doi-asserted-by":"crossref","first-page":"1700451","DOI":"10.1183\/13993003.00451-2017","article-title":"Long-term effects of inhalaed corticosteroids on sputum bacterial and viral loads in COPD","volume":"50","author":"Contoli","year":"2017","journal-title":"Eur Respir J."},{"key":"10.1016\/j.opresp.2023.100234_bib0685","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1136\/thoraxjnl-2021-217160","article-title":"Use of inhaled corticosteroids and risk of acquiring Pseudomonas aeruginosa in patients with chronic obstructive pulmonary disease","volume":"77","author":"Ekl\u00f6f","year":"2022","journal-title":"Thorax."},{"key":"10.1016\/j.opresp.2023.100234_bib0690","doi-asserted-by":"crossref","first-page":"e001067","DOI":"10.1136\/bmjresp-2021-001067","article-title":"Inhaled corticosteroid dose is associated with Pseudomonas aeruginosa infection in severe COPD","volume":"8","author":"Shafiek","year":"2021","journal-title":"BMJ Open Respir Res."},{"key":"10.1016\/j.opresp.2023.100234_bib0695","doi-asserted-by":"crossref","first-page":"3539","DOI":"10.3390\/jcm11123539","article-title":"Use of inhaled corticosteroids and risk of acquiring Haemophilus influenzae in patients with chronic obstructive pulmonary disease","volume":"11","author":"Mohsin","year":"2022","journal-title":"J Clin Med."},{"issue":"11","key":"10.1016\/j.opresp.2023.100234_bib0700","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1164\/rccm.200801-145OC","article-title":"Long-term erytrhromycin therapy is associated with decreased chronic obstructive pulmonary disease exacerbatoins","volume":"178","author":"Seemungal","year":"2008","journal-title":"Am J Respir Crit Care Med."},{"issue":"5","key":"10.1016\/j.opresp.2023.100234_bib0705","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S2213-2600(14)70019-0","article-title":"Azitromycin maintenance treatment in patients with frequent exacerbations chronic obstructive pulmonary disease (COLUMBUS)\u00a0: a randomized, double-blind, placebo-controlled trial","volume":"2","author":"Uzun","year":"2014","journal-title":"Lancet Respir Med."},{"issue":"8","key":"10.1016\/j.opresp.2023.100234_bib0710","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1056\/NEJMoa1104623","article-title":"Azithromycin for prevention of exacerbations of COPD","volume":"365","author":"Albert","year":"2011","journal-title":"N Engl J Med."},{"issue":"1","key":"10.1016\/j.opresp.2023.100234_bib0715","first-page":"CD013198","article-title":"Prophylactic antibiotics for adults with chronic obstructive pulmonary disease: a network meta-analysis","volume":"1","author":"Janjua","year":"2021","journal-title":"Cochrane Database Sys Rev."},{"key":"10.1016\/j.opresp.2023.100234_bib0720","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1136\/thoraxjnl-2016-208599","article-title":"Randomized, double-blind, placebo-controlled trial with azithromycin selects for anti-inflammatory microbial metabolites in the emphysematous lung","volume":"72","author":"Segal","year":"2017","journal-title":"Thorax."},{"key":"10.1016\/j.opresp.2023.100234_bib0725","doi-asserted-by":"crossref","first-page":"e105609","DOI":"10.1371\/journal.pone.0105609","article-title":"The effect of azithromycin in adults with stable neutrophilic COPD: A double blind randomised, placebo controlled trial","volume":"9","author":"Simpson","year":"2014","journal-title":"PLoS One."},{"key":"10.1016\/j.opresp.2023.100234_bib0730","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.rmed.2018.03.035","article-title":"Long-term azithromycin therapy to reduce acute exacerbations in patients with severe chronic obstructive pulmonary disease","volume":"138","author":"Naderi","year":"2018","journal-title":"Respir Med."},{"key":"10.1016\/j.opresp.2023.100234_bib0735","doi-asserted-by":"crossref","first-page":"102095","DOI":"10.1016\/j.pupt.2021.102095","article-title":"The immunomodulatory effects of macrolide antibiotics in respiratory disease","volume":"71","author":"Pollock","year":"2021","journal-title":"Pulm Pharm Ther."},{"issue":"3","key":"10.1016\/j.opresp.2023.100234_bib0740","first-page":"251","article-title":"Nuevos antibi\u00f3ticos inhalados y formas de administraci\u00f3n","volume":"2","author":"M\u00e1iz Carro","year":"2020","journal-title":"OPRESP."},{"issue":"3","key":"10.1016\/j.opresp.2023.100234_bib0745","first-page":"226","article-title":"Las bronquiectasias como enfermedad compleja","volume":"2","author":"Gir\u00f3n","year":"2020","journal-title":"OPRESP."},{"key":"10.1016\/j.opresp.2023.100234_bib0750","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/S2213-2600(19)30185-7","article-title":"The efficacy and safety of inhaled antibiotics for the treatment of bronchiectasis in adults: a systematic review and meta-analysis","volume":"7","author":"Laska","year":"2019","journal-title":"Lancet Respir Med."},{"key":"10.1016\/j.opresp.2023.100234_bib0755","first-page":"100171","article-title":"Enfermedad pulmonar obstructiva cr\u00f3nica","volume":"4","author":"Garc\u00eda Castillo","year":"2022","journal-title":"OPRESP."},{"key":"10.1016\/j.opresp.2023.100234_bib0760","doi-asserted-by":"crossref","first-page":"621","DOI":"10.2147\/COPD.S357491","article-title":"The Impact of Chronic Bronchial Infection in COPD: A Proposal for Management","volume":"17","author":"Martinez-Garcia","year":"2022","journal-title":"Int J Chron Obstruct Pulmon Dis."},{"issue":"1","key":"10.1016\/j.opresp.2023.100234_bib0765","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.arbres.2021.03.009","article-title":"Effectiveness and Safety of Inhaled Antibiotics in Patients With Chronic Obstructive Pulmonary Disease. A Multicentre Observational Study","volume":"58","author":"De la Rosa Carrillo","year":"2022","journal-title":"Arch Bronconeumol."},{"key":"10.1016\/j.opresp.2023.100234_bib0770","doi-asserted-by":"crossref","first-page":"00269","DOI":"10.1183\/23120541.00269-2020","article-title":"Effect of hypertonic saline on mucociliary clearance and clinical outcomes in chronic bronchitis","volume":"6","author":"Bennett","year":"2020","journal-title":"ERJ Open Res."}],"container-title":["Open Respiratory Archives"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2659663623000036?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2659663623000036?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T09:13:41Z","timestamp":1762938821000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2659663623000036"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":77,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["S2659663623000036"],"URL":"https:\/\/doi.org\/10.1016\/j.opresp.2023.100234","relation":{},"ISSN":["2659-6636"],"issn-type":[{"value":"2659-6636","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Infecci\u00f3n bronquial cr\u00f3nica en EPOC estable","name":"articletitle","label":"Article Title"},{"value":"Open Respiratory Archives","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.opresp.2023.100234","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Sociedad Espa\u00f1ola de Neumolog\u00eda y Cirug\u00eda Tor\u00e1cica (SEPAR). Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}],"article-number":"100234"}}